Literature DB >> 5962495

Transglutaminase as a blood clotting enzyme.

J B Lorand, T Urayama, L Lorand.   

Abstract

Mesh：

Substances：

Year:  1966        PMID： 5962495     DOI： 10.1016/0006-291x(66)90562-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  7 in total

1.  A pathological inhibitor of fibrin cross-linking.

Authors:  L Lorand; A Jacobsen; J Bruner-Lorand
Journal:  J Clin Invest       Date:  1968-02       Impact factor: 14.808

2.  Cross-linked A alpha.gamma chain hybrids serve as unique markers for fibrinogen polymerized by tissue transglutaminase.

Authors:  S N Murthy; L Lorand
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

3.  Barnacle cement: a polymerization model based on evolutionary concepts.

Authors:  Gary H Dickinson; Irving E Vega; Kathryn J Wahl; Beatriz Orihuela; Veronica Beyley; Eva N Rodriguez; Richard K Everett; Joseph Bonaventura; Daniel Rittschof
Journal:  J Exp Biol       Date:  2009-11       Impact factor: 3.312

4.  Role of protein transamidation in serotonin-induced proliferation and migration of pulmonary artery smooth muscle cells.

Authors:  Yinglin Liu; Lin Wei; Debra L Laskin; Barry L Fanburg
Journal:  Am J Respir Cell Mol Biol       Date:  2010-06-17       Impact factor: 6.914

5.  Inhibition of transglutaminase exacerbates polyglutamine-induced neurotoxicity by increasing the aggregation of mutant ataxin-3 in an SCA3 Drosophila model.

Authors:  Yunting Lin; Hua He; Yingying Luo; Ting Zhu; Ranhui Duan
Journal:  Neurotox Res       Date:  2014-12-11       Impact factor: 3.911

6.  Cloning and expression of chicken erythrocyte transglutaminase.

Authors:  N Weraarchakul-Boonmark; J M Jeong; S N Murthy; J D Engel; L Lorand
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

7.  Diagnostic and genetic studies on fibrin-stabilizing factor with a new assay based on amine incorporation.

Authors:  L Lorand; T Urayama; J W De Kiewiet; H L Nossel
Journal:  J Clin Invest       Date:  1969-06       Impact factor: 14.808
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.